SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-168270
Filing Date
2019-06-07
Accepted
2019-06-07 16:51:03
Documents
6
Period of Report
2019-06-07

Document Format Files

Seq Description Document Type Size
1 6-K d664810d6k.htm 6-K 8608
2 EX-99.1 d664810dex991.htm EX-99.1 54113
3 EX-99.2 d664810dex992.htm EX-99.2 15767
4 EX-99.3 d664810dex993.htm EX-99.3 8163
5 GRAPHIC g664810g45a87.jpg GRAPHIC 8171
6 GRAPHIC g664810g64s75.jpg GRAPHIC 14554
  Complete submission text file 0001193125-19-168270.txt   119393
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 19886575
SIC: 2836 Biological Products, (No Diagnostic Substances)